CCNB1 and liver cancer: Western blot indicated a dose-dependent reduction in the expression of cyclin B1, an important G2 checkpoint protein, in the two liver cancer cells, suggesting that PP-induced G2 phase cell cycle arrest might be mediated by the down-regulated expression of cyclin B1 (Fig. 1C).